• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

是一种用于胶质瘤预后的新型生物标志物。

Is a New Biomarker for Glioma Prognosis.

作者信息

Liu Zhichun, Liu Junhui, Chen Zhibiao, Zhu Xiaonan, Ding Rui, Huang Shulan, Xu Haitao

机构信息

Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.

出版信息

Biomedicines. 2024 Nov 11;12(11):2579. doi: 10.3390/biomedicines12112579.

DOI:10.3390/biomedicines12112579
PMID:39595145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11591648/
Abstract

BACKGROUND

Chloride Intracellular Channel 4 () plays a versatile role in cellular functions beyond its role in primary chloride ion transport. Notably, many studies found an association between expression and cancers. However, the correlation between and glioma remains to be uncovered.

METHODS

A total of 3162 samples from nine public datasets were analyzed to reveal the relationship between expression and glioma malignancy or prognosis. Immunohistochemistry (IHC) staining was performed to examine the results in an in-house cohort. A nomogram model was constructed to predict the prognosis. Functional enrichment analysis was employed to find -associated differentially expressed genes in glioma. Immune infiltration analysis, correlation analysis, and IHC staining were employed, aiming to examine the correlation between expression, immune cell infiltration, and ECM (extracellular matrix)-related genes.

RESULTS

The expression level of was correlated with the malignancy of glioma and the prognosis of patients. More aggressive gliomas and mesenchymal GBM are associated with a high expression of . Gliomas with IDH mutation or 1p19q codeletion express a low level of , and a high expression of correlates with poor prognosis. The nomogram model shows a good predictive performance. The DEGs (differentially expressed genes) in gliomas with high and low expression are enriched in extracellular matrix and immune functions. On the one hand, gliomas with high expression have a greater presence of macrophages, neutrophils, and eosinophils; on the other hand, a high expression in gliomas is positively associated with ECM-related genes.

CONCLUSIONS

Compared to glioma cells with low expression, gliomas with high expression exhibit greater malignancy and poorer prognosis. Our findings indicate that a high level of correlates with high expression of ECM-related genes and the infiltration of macrophages, neutrophils, and eosinophils within glioma tissues.

摘要

背景

氯离子细胞内通道4(CLIC4)在细胞功能中发挥着多种作用,超出了其在初级氯离子转运中的作用。值得注意的是,许多研究发现CLIC4表达与癌症之间存在关联。然而,CLIC4与胶质瘤之间的相关性仍有待揭示。

方法

分析来自九个公共数据集的总共3162个样本,以揭示CLIC4表达与胶质瘤恶性程度或预后之间的关系。进行免疫组织化学(IHC)染色以在内部队列中检验结果。构建列线图模型以预测预后。采用功能富集分析来寻找胶质瘤中与CLIC4相关的差异表达基因。采用免疫浸润分析、相关性分析和IHC染色,旨在检验CLIC4表达、免疫细胞浸润和细胞外基质(ECM)相关基因之间的相关性。

结果

CLIC4的表达水平与胶质瘤的恶性程度和患者的预后相关。侵袭性更强的胶质瘤和间充质型胶质母细胞瘤与CLIC4的高表达相关。具有异柠檬酸脱氢酶(IDH)突变或1p19q共缺失的胶质瘤表达水平较低,而CLIC4的高表达与预后不良相关。列线图模型显示出良好的预测性能。CLIC4高表达和低表达的胶质瘤中的差异表达基因(DEGs)在细胞外基质和免疫功能方面富集。一方面,CLIC4高表达的胶质瘤中巨噬细胞、中性粒细胞和嗜酸性粒细胞的存在更多;另一方面,胶质瘤中CLIC4的高表达与ECM相关基因呈正相关。

结论

与CLIC4低表达相比,CLIC4高表达的胶质瘤表现出更高的恶性程度和更差的预后。我们的研究结果表明,高水平的CLIC4与胶质瘤组织中ECM相关基因的高表达以及巨噬细胞、中性粒细胞和嗜酸性粒细胞的浸润相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/5e194523f19e/biomedicines-12-02579-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/0d36a8cfd9a9/biomedicines-12-02579-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/6aa8f2c6a4b7/biomedicines-12-02579-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/117fdbe200cc/biomedicines-12-02579-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/e997e085c77f/biomedicines-12-02579-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/615b42a6fdb9/biomedicines-12-02579-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/09948eefd33d/biomedicines-12-02579-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/41b1f53edd8f/biomedicines-12-02579-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/5a46781dc1cc/biomedicines-12-02579-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/bfbc9357074f/biomedicines-12-02579-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/5e194523f19e/biomedicines-12-02579-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/0d36a8cfd9a9/biomedicines-12-02579-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/6aa8f2c6a4b7/biomedicines-12-02579-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/117fdbe200cc/biomedicines-12-02579-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/e997e085c77f/biomedicines-12-02579-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/615b42a6fdb9/biomedicines-12-02579-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/09948eefd33d/biomedicines-12-02579-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/41b1f53edd8f/biomedicines-12-02579-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/5a46781dc1cc/biomedicines-12-02579-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/bfbc9357074f/biomedicines-12-02579-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8701/11591648/5e194523f19e/biomedicines-12-02579-g010.jpg

相似文献

1
Is a New Biomarker for Glioma Prognosis.是一种用于胶质瘤预后的新型生物标志物。
Biomedicines. 2024 Nov 11;12(11):2579. doi: 10.3390/biomedicines12112579.
2
MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.MCM10 作为一种新型的预后生物标志物及其与胶质瘤免疫浸润的相关性。
Technol Health Care. 2023;31(4):1301-1317. doi: 10.3233/THC-220576.
3
MELK is a prognostic biomarker and correlated with immune infiltration in glioma.MELK是一种预后生物标志物,与胶质瘤中的免疫浸润相关。
Front Neurol. 2022 Oct 24;13:977180. doi: 10.3389/fneur.2022.977180. eCollection 2022.
4
Integrated bioinformatics analysis and experimental validation on malignant progression and immune cell infiltration of LTBP2 in gliomas.胶质瘤中 LTBP2 的恶性进展和免疫细胞浸润的综合生物信息学分析和实验验证。
BMC Cancer. 2024 Oct 10;24(1):1252. doi: 10.1186/s12885-024-12976-2.
5
Construction and validation of a risk model based on the key SNARE proteins to predict the prognosis and immune microenvironment of gliomas.基于关键SNARE蛋白构建和验证风险模型以预测胶质瘤的预后和免疫微环境
Front Mol Neurosci. 2023 Dec 5;16:1304224. doi: 10.3389/fnmol.2023.1304224. eCollection 2023.
6
Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.基于细胞外基质相关基因的胶质瘤风险特征的识别与验证
Medicine (Baltimore). 2021 Apr 23;100(16):e25603. doi: 10.1097/MD.0000000000025603.
7
DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.DNAJC10 与肿瘤免疫特征相关,并可预测胶质瘤患者的预后。
Biosci Rep. 2022 Jan 28;42(1). doi: 10.1042/BSR20212378.
8
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.系统地描述 1p/19q 非缺失型脑胶质瘤中 1p19q 基因的临床和生物学意义。
Carcinogenesis. 2019 Oct 16;40(10):1229-1239. doi: 10.1093/carcin/bgz102.
9
Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns.基于免疫细胞浸润模式不良特征基因的胶质瘤患者优化风险分层策略。
J Cancer Res Clin Oncol. 2023 Nov;149(15):13855-13874. doi: 10.1007/s00432-023-05209-9. Epub 2023 Aug 3.
10
CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.CHI3L2是一种新型的预后生物标志物,与胶质瘤中的免疫浸润相关。
Front Oncol. 2021 Apr 15;11:611038. doi: 10.3389/fonc.2021.611038. eCollection 2021.

引用本文的文献

1
Novel metabolic subtypes in IDH-mutant gliomas: implications for prognosis and therapy.异柠檬酸脱氢酶(IDH)突变型胶质瘤中的新型代谢亚型:对预后和治疗的意义
BMC Cancer. 2025 Apr 30;25(1):815. doi: 10.1186/s12885-025-14176-y.
2
The role of chloride intracellular channel 4 in tumors.氯离子细胞内通道4在肿瘤中的作用。
Cancer Cell Int. 2025 Mar 26;25(1):118. doi: 10.1186/s12935-025-03737-7.